These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29076670)

  • 1. Effects of nigella sativa on various parameters in Patients of non-alcoholic fatty liver disease.
    Hussain M; Tunio AG; Akhtar L; Shaikh GS
    J Ayub Med Coll Abbottabad; 2017; 29(3):403-407. PubMed ID: 29076670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial.
    Darand M; Darabi Z; Yari Z; Saadati S; Hedayati M; Khoncheh A; Hosseini-Ahangar B; Alavian SM; Hekmatdoost A
    Complement Ther Med; 2019 Jun; 44():204-209. PubMed ID: 31126557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease.
    Hussain M; Majeed Babar MZ; Hussain MS; Akhtar L
    Pak J Med Sci; 2016; 32(6):1396-1401. PubMed ID: 28083033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tang G; Zhang L; Tao J; Wei Z
    Phytother Res; 2021 Aug; 35(8):4183-4193. PubMed ID: 33728708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial.
    Khonche A; Huseini HF; Gholamian M; Mohtashami R; Nabati F; Kianbakht S
    J Ethnopharmacol; 2019 Apr; 234():106-111. PubMed ID: 30639231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients.
    Hussain M; Habib-Ur-Rehman ; Akhtar L
    Pak J Med Sci; 2017; 33(4):931-936. PubMed ID: 29067068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial.
    Darand M; Darabi Z; Yari Z; Hedayati M; Shahrbaf MA; Khoncheh A; Hosseini-Ahangar B; Alavian SM; Hekmatdoost A
    Phytother Res; 2019 Sep; 33(9):2369-2377. PubMed ID: 31293021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial.
    Rashidmayvan M; Vandyousefi S; Barati M; Salamat S; Ghodrat S; Khorasanchi M; Jahan-Mihan A; Nattagh-Eshtivani E; Mohammadshahi M
    Complement Ther Clin Pract; 2022 Aug; 48():101598. PubMed ID: 35567872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
    Lim SL; Johal J; Ong KW; Han CY; Chan YH; Lee YM; Loo WM
    JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14802. PubMed ID: 32281943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) - 1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial.
    Farhangi MA; Dehghan P; Tajmiri S; Abbasi MM
    BMC Complement Altern Med; 2016 Nov; 16(1):471. PubMed ID: 27852303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counter effects of N. Sativa L. and P. ovate L. on indicative markers of non alcoholic fatty liver disease.
    Abbas AS; Sheikh N
    Pak J Pharm Sci; 2016 Jan; 29(1):185-91. PubMed ID: 26826811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Nigella sativa Seed Extract for Hypertension in Elderly: a Double-blind, Randomized Controlled Trial.
    Rizka A; Setiati S; Lydia A; Dewiasty E
    Acta Med Indones; 2017 Oct; 49(4):307-313. PubMed ID: 29348380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease.
    Dohil R; Schmeltzer S; Cabrera BL; Wang T; Durelle J; Duke KB; Schwimmer JB; Lavine JE
    Aliment Pharmacol Ther; 2011 May; 33(9):1036-44. PubMed ID: 21395631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.
    de Jonge C; Rensen SS; Koek GH; Joosten MF; Buurman WA; Bouvy ND; Greve JW
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1517-20. PubMed ID: 23920034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.
    Mofidi F; Poustchi H; Yari Z; Nourinayyer B; Merat S; Sharafkhah M; Malekzadeh R; Hekmatdoost A
    Br J Nutr; 2017 Mar; 117(5):662-668. PubMed ID: 28345499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of Nigella sativa seeds against carbon tetrachloride-induced liver damage.
    Al-Ghamdi MS
    Am J Chin Med; 2003; 31(5):721-8. PubMed ID: 14696675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenugreek, Nigella, and termis seeds in nonalcoholic fatty liver in obese diabetic albino rats.
    Mohamed WS; Mostafa AM; Mohamed KM; Serwah AH
    Arab J Gastroenterol; 2015 Mar; 16(1):1-9. PubMed ID: 25670619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.